Jump | Free Trial Issue
Search Quote
U.S.  |  EUROPE  |  ASIA HOME PAGE FOR THE WORLD'S BUSINESS LEADERS
 
Home > Markets > Equities > CardioTech International, Inc. 		   
CardioTech International, Inc. (AMEX: CTE)

Industry: Medical Equipment & Supplies
Sector: Healthcare 		 
Price: 2.01 Change: -.1800 %Change: -8.22
Thu Mar 24 2005 15:59 EST | 15 min quote delay
Open: 2.09
High: 2.11
Low: 1.98
Volume: 73,500
52-Week High: 5.25
52-Week Low: 1.80
YTD %Change: -31.86
Avg Vol(3 mo.):¹ 0.06
  Click for Advanced Chart
Charting powered by Prophet.Net
  Advanced Chart
Buy, Sell, Hold CTE? Get a Second OpinionTM
News
   No news found in the past 30 days.


Press Releases
03.01.05  CardioTech International Open Letter to Shareholders
More Press Releases On CardioTech International, Inc.


Background
CTE develops and manufactures small bore vascualar grafts, or synthethic blood vessels. It also develops, manufactures & markets biomaterials for use in implanted devices. For the 6 months ended 12/31/04, revenues rose less than 1% to $16.1M. Net loss increased 35% to $968K. Revenues reflect higher contract manufacturing revenues. Net loss reflects the inclusion of $37K equity in loss on CorNova, Inc.                 

Financials & Ratios
Book Value/Share ($) 1.11
Cash Per Share ($) 0.41
Current Ratio (MRQ) 6.82
Div/Yield % NA
Earn/Shr ($) -0.10
Ex-Div Amt. ($) NA
Ex-Div Date NA
Float¹ 14.90
Market Cap¹ 37.91
P/E (TTM) NM
Price/Book (MRQ) 1.81
Price/Cash Flow (TTM) NM
Price/Revenue (TTM) 1.68
ROA (TTM) -7.96
ROE (TTM) -9.16
Shares Out¹ 18.86
Total Debt/Equity (MRQ) 0.00
TTM: trailing 12 months   MRQ: most recent quarter   ¹ Units in millions


Revenues (Millions of U.S. Dollars USD)  
Last Quarter 5


Earnings Per Share (U.S. Dollars USD)  
Last Quarter -0.04
Earnings per share data excludes extraordinary items
Earnings estimates
FY 2005 -0.07**
Earnings estimates from First Call. Data includes extraordinary items
** based on estimates from 2 brokers.


Growth Rates
1 Year 5 Year
Revenue % 542.28 82.29
EPS % NM NM
Divdend % NM NM


Short Interest
Current Month* 0.66
Previous Month* 0.67
Short Interest Ratio 16.57


Institutional & Insider Ownership (Millions of Shares) 
Purchases Sale Net Purch.
Institutions 0.13 0.27 -0.14
Insiders 0.00 0.00 0.00
Institutional data based on company's quarterly reporting,
insiders on a 6-month rolling basis.


 Corporate Events
   No Upcoming Events found for this company.


Equity:
Common Stock $.01 Par, 12/04, 50M auth., 18,922,984 issd., less 135,754 shs. in Treas. @ cost. Insiders control 21% (incl. 4.3M in options). Stock issued 6/96, through a spinoff of PolyMedica Industries. *4/03, Company acquired Gish Biomedical, Inc. @ 1.3422 shs. (4,821,377 shares issd.).               

Analyst Footnotes:
3/00, All preferred stock converted into 353,123 shs. of common at a price of $1.5842. FY '02 Qs are reclassified.     

NM: not meaningful   
StocksPeopleLookup
 Stock & Funds
Enter company or fund
   
 Visit Triggernews.com
 Free Portfolio Tracker
 People Tracker
 Real-Time Prices Stock Portfolio
 IT Research Library
 White Papers Library


E-Mail Alerts
Company
  CardioTech International, Inc.
Topics
  Medical Equipment & Supplies
  Healthcare
Enter E-Mail Address:
 FAQ Privacy Policy 
Company Data
   229 Andover Street
Wilmington,  MA   01887
Phone: (978) 657-0075
investor-info@cardiotech-inc.com


Forbes Lists
   Currently not on a Forbes List for U.S. companies.
See all Forbes lists


Officers
   Michael  Szycher, Ph.D.
   Leslie M Taeger
   Michael  Adams
   Anthony J Armini, Ph.D.
   Michael L Barretti
   Jeremiah E Dorsey
   Willaim  O'Niel, Jr.
   Thomas F Lovett
More executives at CTE


More Companies like this
  Companies in the same industry
  Companies with similar market caps
  Companies with similar YTD % change stock performance
  Funds with CTE in their top 5 holdings




Additional Company Info
  News
Events
Executives
Annual Reports
Advanced Chart



 

 
Is Jim Cramer trading CTE in his personal $3 million portfolio?
Find out for FREE!



 

SitemapHelpContact Forbes.comInvestment NewslettersForbes ConferencesForbes Magazines
Ad Information   Forbes.com Wireless   Reprints/Permissions   Subscriber Services  
© 2005 Forbes.com Inc.™   All Rights Reserved   Privacy Statement   Terms, Conditions and Notices


Stock quotes are delayed at least 15 minutes for Nasdaq, at least 20 minutes for NYSE/AMEX. U.S. indexes are delayed at least 15 minutes with the exception of Nasdaq, Dow Jones Industrial Average and S&P; 500 which are 2 minutes delayed. Disclaimer Mutual Fund data provided by Morningstar Forbes 40 Index powered by Telemet. News may include latest headlines from Reuters. Exchange trademark and copyright notices. Fundamental company data from Reuters. Earnings dates and conference call data provided by StreetEvents, a service of CCBN.com. 2001 CCBN.com, Inc. All rights reserved.


Powered By